Furthermore, these findings align with previous studies implicating cytoskeletal regulators, such as PALLD, in cancer progression and metastasis, reinforcing the idea that modulating the actin cytoskeleton may offer a promising strategy for cancer therapy. This evidence concerns the gene PALLD and cancer.